Polybasic peptide–levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria

To address the rising threat of multidrug-resistant (MDR) bacteria, new therapeutic strategies must be developed.